UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES

    EXCHANGE ACT OF 1934

For the month of August 2023

Commission File Number: 001-38885

ORGANIGRAM HOLDINGS INC.

(Translation of registrant’s name into English)

145 King Street West, Suite 1400

Toronto, Ontario, Canada M5H 1J8

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [ ] Form 40-F [ X ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]

SUBMITTED HEREWITH

Exhibits

99.1	News release dated August 21, 2023

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ORGANIGRAM HOLDINGS INC.

/s/ Derrick West

Derrick West

Chief Financial Officer

Date: August 21, 2023

Exhibit 99.1

Organigram Relaunches one of Canada’s First Cannabis Brands, Trailblazer

Trailblazer returns to the Canadian marketplace with a new range of products

TORONTO--(BUSINESS WIRE)--August 21, 2023--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the relaunch of one of Canada’s best known cannabis brands, Trailblazer, exemplifying the Company’s commitment to keeping consumer insights at the heart of its brand and product development strategy. More than a year in the making, Trailblazer’s modernized brand identity and revitalized product lineup represent a significant opportunity to connect with a large and important consumer segment whose needs were previously unmet by the Organigram brand portfolio. Featuring THCV gummies, CBG infused pre-rolls and a high-potency 1x0.5g pre-roll, Trailblazer will re-enter the market with a range of differentiated offerings.

According to the Company’s segmentation research, the target audience for the new Trailblazer brand identity represents approximately $1.2B in total cannabis retail sales.^1^ One key differentiating factor for this segment is the prioritization of whole-plant wellness and the self-administered benefits of the cannabis plant for restorative needs such as relaxation as opposed to pure recreational product enjoyment. They also prefer high THC products and the presence of minor cannabinoids.

The new Trailblazer portfolio consists of three new products, with additional products expected to be launched in Organigram’s upcoming fiscal year:

Cherry Comfort: Diamonds + Distillate Infused THC+CBG Pre-rolls
- 3 x 0.5g pre-rolls
- +30% THC; +5% CBG with a total cannabinoid potency of +35%
- Each half-gram cone is infused with THC + CBG distillate and THCA diamonds
Zen Garden Grapefruit 2:1 THCV: THC Sugar-free Gummies
- 4 sugar-free gummies
- 5 mg of THCV and 2.5 mg THC per gummy
- THCV derived from whole flower grown in Moncton
- Made with natural flavours, THCV and THC distillate
Dank Dreams: A Potent and Convenient Single Pre-roll
- 0.5g pre-roll
- Curated Indica flower
- High potency with 22-26% THC

“By understanding the unique preferences and aspirations of our Trailblazer target audience, we strived to create a deeply rewarding brand experience that fosters a sense of understanding, positivity, and empowerment. The brand positioning reflects the emotional aspirations of this consumer segment, reflecting a brand that is designed for a modern legal cannabis consumer. Trailblazer aims to create a positive and uplifting experience for its consumers, supporting them in their cannabis journey”, says Megan McCrae, Senior Vice President, Marketing and Communications at Organigram.

About Organigram Holdings Inc. Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada.

Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Forward-Looking Information This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes to market conditions, consumer preferences, regulatory changes and constraints, and factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

^_____________ 1^ HiFyre Data

Contacts

For Investor Relations enquiries:

        **Max Schwartz** 

        Director of Investor Relations ****            investors@organigram.ca

        Organigram

For Media enquiries:

        **Megan McCrae** 

        Senior Vice President – Marketing and Communications 

        megan.mccrae@organigram.ca

        Organigram